Pathophysiology of Influenza A Virus-induced Lung Injury in Juveniles
甲型流感病毒引起的青少年肺损伤的病理生理学
基本信息
- 批准号:9756467
- 负责人:
- 金额:$ 16.12万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-08-06 至 2022-06-30
- 项目状态:已结题
- 来源:
- 关键词:AcuteAcute Lung InjuryAdolescentAdultAdult Respiratory Distress SyndromeAgeAlveolarAlveolar MacrophagesAnimal ModelAntibodiesAntiviral AgentsAntiviral ResponseAntiviral TherapyAutomobile DrivingCCL2 geneCCR1 geneCell modelCellsCessation of lifeChildChildhoodChildhood InjuryClinicalClinical DataCommunicationCoupledCritically ill childrenDataData AnalysesDevelopmentDiseaseDisease ProgressionEpidemicEpithelial CellsEquilibriumExperimental DesignsExpression ProfilingFosteringFunctional disorderGene ExpressionGoalsIRF3 geneITGAX geneImmune responseImmunologic MemoryImpairmentInfectionInfection ControlInflammasomeInflammatoryInflammatory ResponseInfluenzaInfluenza A virusInnate Immune ResponseInterferon-alphaInterferon-betaInterleukin-1 betaInterleukin-18InterventionKnowledgeLaboratory ProceduresLifeLungLung InflammationMediatingMedicalMentorsMorbidity - disease rateMusPathogenesisPathway interactionsPatientsPeripheralPhysiciansPneumoniaPopulationPreventionProcessProductionReceptor ActivationReceptor SignalingRegulationResearchRespiratory Tract InfectionsRiskRoleScientistSignal TransductionSupportive careTestingTherapeuticTissuesTrainingTraining ProgramsTranslatingViralViral PneumoniaViral Respiratory Tract InfectionVirusVirus DiseasesVirus ReplicationVulnerable Populationsalveolar type II cellbasecell typechemokine receptorclinically relevantdesigngamma-Chemokinesin vitro Modelin vivolaboratory experiencelung developmentlung injurymature animalmonocytemonocyte chemoattractant protein 1 receptormortalitymouse modelnovelnovel therapeuticspandemic diseasepatient populationpediatric patientspreventreceptorreceptor expressionrecruitresponseskillstooltranscriptometranscriptome sequencing
项目摘要
PROJECT SUMMARY
The broad objectives of this K08 proposal are two-fold: (1) to foster the development of essential scientific and
professional skills that will allow the candidate, Dr. Bria Coates, to achieve her long-term goal of becoming an
independent physician-scientist concentrating on the development of acute lung injury in children with viral
respiratory infections and seeking solutions that could be translated for therapeutic benefit to critically ill
children, and (2) to investigate mechanisms that regulate the immune response to influenza A virus (IAV) and
contribute to increased morbidity and mortality in the pediatric patient population. Through laboratory
experience, didactic coursework, and the collaborative process, Dr. Coates will gain expertise in experimental
design, laboratory procedures, data analysis, and scientific communication. Dr. Coates and her mentor, Dr.
Karen Ridge, have designed a specific training plan that will afford Dr. Coates new knowledge and research
skills in the pathophysiology of acute lung inflammation and acute respiratory distress syndrome (ARDS),
which is a lung condition that causes tremendous morbidity and mortality in young patients with viral
respiratory infections. Importantly, recent clinical data thwart the long-standing dogma that children with
influenza have increased morbidity and mortality due to impaired viral clearance. Our preliminary data identify
an altered innate immune response in IAV-infected juvenile mice as a critical parameter in disease
progression. Specifically, we show that increased lung injury in IAV-infected juvenile mice is associated with
robust activation of the NOD-like receptor (NLR) proteins NOD2 and the NLRP3, resulting in increased IFNα/β
and IL-1β/18 levels, respectively, that persist beyond viral elimination. In addition, juvenile lungs produce more
MCP-1 and recruit more inflammatory monocytes during IAV infection, which then perpetuates NOD2 and
NLRP3 activation. We observe that juvenile recruited monocytes are uniquely inflammatory, and prevention of
their recruitment during IAV infection protects juvenile mice from IAV-mediated lung injury. We hypothesize
that age-specific, cell autonomous differences in the innate immune response to IAV contribute to the
robust and sustained activation of NLR proteins and exacerbate IAV-induced lung injury in juvenile
mice. We have formulated three interrelated specific aims to study the regulation of monocyte recruitment and
NLR signaling in both in vivo and in vitro models of juvenile IAV-induced lung injury. Specific Aim 1:
Investigate the age-specific mechanisms that modulate the activation of NLR proteins in response to IAV
infection and contribute to IAV-induced acute lung injury. Specific Aim 2: Determine whether recruited
monocytes are required for IAV-mediated acute lung injury in juvenile mice. Specific Aim 3: Identify cell
autonomous differences in juvenile IAV infection that may drive age-specific inflammatory responses.
Completion of these aims will provide a rigorous training program for Dr. Coates and uncover mechanisms
driving acute lung injury in children with viral respiratory infections.
项目概要
K08 提案的广泛目标有两个:(1) 促进基本科学和技术的发展
专业技能将使候选人 Bria Coates 博士能够实现成为一名
独立医师科学家,专注于病毒感染儿童急性肺损伤的发展
呼吸道感染并寻求可以转化为危重病人治疗效果的解决方案
儿童,(2) 研究调节甲型流感病毒 (IAV) 免疫反应的机制和
通过实验室,导致儿科患者发病率和死亡率增加。
经验、教学课程和协作过程,科茨博士将获得实验方面的专业知识
设计、实验室程序、数据分析和科学交流。
Karen Ridge 设计了一个具体的培训计划,为 Coates 博士提供新的知识和研究
急性肺部炎症和急性呼吸窘迫综合征(ARDS)的病理生理学技能,
这是一种肺部疾病,会导致年轻病毒感染者发病率和死亡率极高
重要的是,最近的临床数据打破了长期以来认为儿童患有呼吸道感染的教条。
我们的初步数据表明,由于病毒清除受损,流感的发病率和死亡率增加。
感染 IAV 的幼年小鼠先天免疫反应的改变是疾病的关键参数
具体来说,我们发现感染 IAV 的幼年小鼠的肺损伤增加与
NOD 样受体 (NLR) 蛋白 NOD2 和 NLRP3 的强烈激活,导致 IFNα/β 增加
和 IL-1β/18 水平分别在病毒消除后持续存在。此外,幼年肺部产生更多。
MCP-1 并在 IAV 感染期间招募更多炎症单核细胞,从而使 NOD2 和
我们观察到幼年募集的单核细胞具有独特的炎症性,并且可以预防
它们在 IAV 感染期间的募集可以保护幼年小鼠免受 IAV 介导的肺损伤。
年龄特异性、细胞自主性对 IAV 的先天免疫反应的差异有助于
NLR 蛋白的强烈和持续激活并加剧 IAV 引起的青少年肺损伤
我们制定了三个相互关联的具体目标来研究单核细胞募集和的调节。
幼年 IAV 诱导的肺损伤体内和体外模型中的 NLR 信号传导 具体目标 1:
研究调节 NLR 蛋白响应 IAV 激活的年龄特异性机制
感染并导致 IAV 引起的急性肺损伤 具体目标 2:确定是否招募。
单核细胞是 IAV 介导的幼年小鼠急性肺损伤所必需的。 具体目标 3:识别细胞。
青少年 IAV 感染的自主差异可能会驱动年龄特异性炎症反应。
完成这些目标将为科茨博士提供严格的培训计划并揭示机制
导致患有病毒性呼吸道感染的儿童发生急性肺损伤。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Bria M Coates其他文献
Bria M Coates的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Bria M Coates', 18)}}的其他基金
Elucidating the role of type I interferon signaling and macrophage-derived inflammation in the juvenile host with viral pneumonia
阐明 I 型干扰素信号传导和巨噬细胞衍生炎症在病毒性肺炎幼年宿主中的作用
- 批准号:
10651426 - 财政年份:2023
- 资助金额:
$ 16.12万 - 项目类别:
Pathophysiology of Influenza A Virus-induced Lung Injury in Juveniles
甲型流感病毒引起的青少年肺损伤的病理生理学
- 批准号:
10208942 - 财政年份:2018
- 资助金额:
$ 16.12万 - 项目类别:
Pathophysiology of Influenza A Virus-induced Lung Injury in Juveniles
甲型流感病毒引起的青少年肺损伤的病理生理学
- 批准号:
10208942 - 财政年份:2018
- 资助金额:
$ 16.12万 - 项目类别:
相似国自然基金
免疫反应基因1(IRG1)在急性肺损伤中的作用及其转录调控机制研究
- 批准号:82300103
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
TRPV2-AMPK-PKM2信号轴介导的巨噬细胞能量代谢重编程在衰老后肠缺血再灌注所致急性肺损伤中的作用及机制
- 批准号:82372201
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
Galectin-1抑制肺泡巨噬细胞线粒体损伤介导的NLRP3活化减轻流感致急性肺损伤的机制研究
- 批准号:82300005
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
ANXA3调控肺微血管内皮细胞通透性在脓毒症急性肺损伤中的作用及机制研究
- 批准号:82372180
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
PDHA1介导中性粒细胞NETosis在急性肺损伤中的作用及机制研究
- 批准号:82370086
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Preclinical development of a synthetic lung surfactant dry powder aerosol for hypoxemia or acute respiratory distress syndrome patients receiving different modes of ventilation support
用于接受不同通气支持模式的低氧血症或急性呼吸窘迫综合征患者的合成肺表面活性剂干粉气雾剂的临床前开发
- 批准号:
10658610 - 财政年份:2023
- 资助金额:
$ 16.12万 - 项目类别:
The impact of vaping aerosol exposure on innate pulmonary defense mechanisms in nonhuman primates
电子烟气溶胶暴露对非人灵长类动物先天肺防御机制的影响
- 批准号:
10428016 - 财政年份:2022
- 资助金额:
$ 16.12万 - 项目类别:
Pulmonary Disfunction after Polysubstance Exposure: Mechanistic Identification of Inflammatory Mediators
多物质暴露后的肺功能障碍:炎症介质的机制识别
- 批准号:
10334101 - 财政年份:2022
- 资助金额:
$ 16.12万 - 项目类别:
The impact of vaping aerosol exposure on innate pulmonary defense mechanisms in nonhuman primates
电子烟气溶胶暴露对非人灵长类动物先天肺防御机制的影响
- 批准号:
10594499 - 财政年份:2022
- 资助金额:
$ 16.12万 - 项目类别:
Cationic CAMKIIN nanoparticles that reduce chlorine-induced airway oxidative stress
阳离子 CAMKIIN 纳米颗粒可减少氯诱导的气道氧化应激
- 批准号:
10698067 - 财政年份:2022
- 资助金额:
$ 16.12万 - 项目类别: